Tangeretin Reduces Severity Of Exercise-induced Bronchoconstriction In Professional Athletes

PURPOSE: To investigate the effects of tangeretin supplementation on auxiliary indicators of exercise-induced bronchoconstriction (EIB), thereby evaluating its therapeutic effects. METHODS: Placebo controlled double-blinded randomized trial was performed on 30 elite athletes with EIB (14 females and 16 males). They were paired and divided into tangeretin intervention group (TIG) or placebo control group (PCG). Both group performed bronchial provocation tests before and after invention. Airway inflammation (eosinophi, neutrophil, basophil, IL-5, IL-8, CC16, IgE), pulmonary ventilation (FEV1, FVC, rate of decline of FEV1) and respiratory symptoms (cough, wheeze, chest tightness) were evaluated before and after the bronchial provocation tests. Chi-square test, independent sample t test and repeated measure analysis of variances were performed. RESULTS: TIG showed significantly lower level of the eosinophil count (P = 0.049), neutrophil count (P = 0.039), IL-5 (P = 0.037), IL-8 (P = 0.003) and IgE (P = 0.011) than the baseline after intervention, and significantly lower level of the IL-5 (P = 0.022) and IL-8 (P = 0.012) than PCG at T5. TIG displayed significantly higher value of the FEV1 (P < 0.01), FVC (P < 0.01), PEF (P = 0.047) and MMF (P = 0.039) than those in the first exercise challenge test (ECT1). Meanwhile, 6 athletes became EIB-negative after intervention, and negative conversion rate of EIB was 40.00%. Additionally, the number of cough symptoms decreased from 9 to 3 and dyspnea from 4 to 2 in TIG. CONCLUSION: Tangeretin supplementation can significantly improve pulmonary ventilation function through inhibiting airway inflammation and relieving respiratory symptoms when athletes with EIB performing high-intensity exercise. Simultaneously, the EIB related symptoms were disappeared for some athletes with EIB after intervention. Tangeretin supplementation showed good therapeutic effects on EIB and was recommended to professional athletes with EIB.

Authors

Institutions

Publication Details

Journal
Medicine & Science in Sports & Exercise
Published
2025-09-16
DOI
https://doi.org/10.1249/01.mss.0001160328.86858.3f
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tangeretin Reduces Severity Of Exercise-induced Bronchoconstriction In Professional Athletes

Zhi Min Cao, Binghong Gao, Zheng Zhang, Meng Liu et al.
Medicine & Science in Sports & Exercise
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Tangeretin Reduces Severity Of Exercise-induced Bronchoconstriction In Professional Athletes

Zhi Min Cao, Binghong Gao, Zheng Zhang, Meng Liu, Shimin Mo
article en

Abstract

PURPOSE: To investigate the effects of tangeretin supplementation on auxiliary indicators of exercise-induced bronchoconstriction (EIB), thereby evaluating its therapeutic effects. METHODS: Placebo controlled double-blinded randomized trial was performed on 30 elite athletes with EIB (14 females and 16 males). They were paired and divided into tangeretin intervention group (TIG) or placebo control group (PCG). Both group performed bronchial provocation tests before and after invention. Airway inflammation (eosinophi, neutrophil, basophil, IL-5, IL-8, CC16, IgE), pulmonary ventilation (FEV1, FVC, rate of decline of FEV1) and respiratory symptoms (cough, wheeze, chest tightness) were evaluated before and after the bronchial provocation tests. Chi-square test, independent sample t test and repeated measure analysis of variances were performed. RESULTS: TIG showed significantly lower level of the eosinophil count (P = 0.049), neutrophil count (P = 0.039), IL-5 (P = 0.037), IL-8 (P = 0.003) and IgE (P = 0.011) than the baseline after intervention, and significantly lower level of the IL-5 (P = 0.022) and IL-8 (P = 0.012) than PCG at T5. TIG displayed significantly higher value of the FEV1 (P < 0.01), FVC (P < 0.01), PEF (P = 0.047) and MMF (P = 0.039) than those in the first exercise challenge test (ECT1). Meanwhile, 6 athletes became EIB-negative after intervention, and negative conversion rate of EIB was 40.00%. Additionally, the number of cough symptoms decreased from 9 to 3 and dyspnea from 4 to 2 in TIG. CONCLUSION: Tangeretin supplementation can significantly improve pulmonary ventilation function through inhibiting airway inflammation and relieving respiratory symptoms when athletes with EIB performing high-intensity exercise. Simultaneously, the EIB related symptoms were disappeared for some athletes with EIB after intervention. Tangeretin supplementation showed good therapeutic effects on EIB and was recommended to professional athletes with EIB.

Medicine & Science in Sports & ExerciseVol. 57(10S)
China Pharmaceutical University (CN), Shenzhen University (CN), Shanghai University of Sport (CN), Chongqing Academy of Environmental Science (CN)
Openalex Percentile: Top 64%
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.